Furthermore, KMO activity has been studied in bipolar disorder (BD), a reduced KMO gene expression has been described in the prefrontal cortex of patients with BD with psychotic feature compared with BP patients without psychotic traits [49] (Table 1). This evidence concerns the gene KMO and bipolar disorder.